Key enzymes in complex biosynthesis could enable alkaloid production

Sales rise as the new firm with 2 old names leads the ranking

CAR T-cell therapy works wonders for some cancer patients. For others, it is a death sentence. To make the revolutionary therapy work for more people, scientists must devise better ways to control it

Protecting coral reefs is the legislation’s goal

‘Brain gain’ program brings high-profile international researchers to Canadian universities

Fellows and Foreign Members are recognized for their exceptional contributions to science

BASF, Borealis, Covestro, and Solvay bring in new CEOs as they report first-quarter results

El profesor de Química y bloguero de Compound Interest Andy Brunning explica los parecidos y las diferencias entre ambos productos de baño.

Semisynthesis aids study of posttranslational modifications to key Alzheimer’s protein

With $45 billion investment, national oil firm seeks diversification away from oil and gas

The start-up, based on the work of Broad Institute scientist Aviv Regev, has raised $65 million to develop therapies for cancer and autoimmune disease

CAS selects Ph.D. and postdoctoral researchers to help shape scientific information

El triclorofluorometano probablemente se origine en fábricas del este de Asia

Listen as we visit the Smithsonian to learn how stable isotope analysis can reveal the stories behind skeletons

In cells, inhibitor created by fragment-based drug design prevents rhinovirus from reproducing

Strong demand and Chinese environment controls lead to robust earnings

With $40 million series A funding, the start-up will develop inhibitors of proteins that make chemical modifications to RNA

Exhibitors at CPhI North America report another year of record growth and investment

Business is booming, but the industry is handicapped by shifting rules and major research gaps

Big investments are planned in Abu Dhabi, Qatar, and Algeria to diversify away from oil and gas

Move will leave agency with three of five board members

Funds from the Gates Foundation and U.K. government will help address antimicrobial resistance in low- and middle-income countries

Agency plans legal limit on four PFASs in drinking water, creating liability for PFOS and PFOA contamination

Flush with another $300 million, Grail plans to enroll 135,000 people in studies this year to detect circulating tumor-derived DNA

Hydrophilic and hydrophobic molecules don’t have to leave their natural environments to react

Las marcas como Juul liberan una forma de nicotina menos agresiva al inhalarse que la nicotina en forma básica.

Products made in volumes between 1 and 100 metric tons must be registered by May 31

Provoked by Trump, a wave of candidates pushes for evidence-based governing

Goal is getting Pfizer-owned land in New Jersey back into use

Move will leave agency with 3 of 5 board members

Funds from the Gates Foundation and U.K. government will help address antimicrobial resistance in low- and middle-income countries

Agency urges the chemical industry to better prepare for extreme weather

The chemist and former college president leads the Association of American Universities in challenging times

Dynamic boron-oxygen networks are key to the new material’s unusual properties

A new report from the Cancer Research Institute highlights the U.S. and China as cell therapy leaders

With so many ingredients on hand, can the oncology community figure out how to sensibly and efficiently combine checkpoint inhibitors with other drugs?